AVITA Medical RCEL

$ 12.61 0.64%

Quarterly report 2024-Q3
added 11-07-2024

AVITA Medical Balance Sheet 2011-2024 | RCEL

Annual Balance Sheet AVITA Medical

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	18.6 M	-17.2 M	-53.9 M	-71.7 M	-20.3 M	-10.8 M	-2.91 M	-3.12 M	-190 K	-3.43 M	-9.69 M	-8.42 M	-13.5 M
Long Term Debt	39.8 M	306 K	918 K	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	895 K	612 K	720 K	533 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	2.35 M	466 K	98.7 K	-	-	-	-	-	-	-
Total Current Liabilities	13.2 M	10.7 M	9.15 M	7.71 M	-	-	-	-	-	-	-	-	-
Total Liabilities	61.9 M	13 M	11.4 M	10.1 M	4.87 M	2.95 M	1.96 M	1.31 M	941 K	1.68 M	2.24 M	2.2 M	1.54 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-298 M	-263 M	-236 M	-195 M	-129 M	-109 M	-102 M	-90.4 M	-87 M	-100 M	-94.9 M	-98.9 M	-95.2 M
Total Assets	112 M	98.3 M	116 M	82.5 M	25.7 M	16.9 M	5.89 M	6.42 M	4.17 M	6.89 M	11.8 M	11 M	18.7 M
Cash and Cash Equivalents	22.1 M	18.2 M	55.5 M	73.6 M	20.4 M	11 M	-	-	-	-	-	-	-
Book Value	49.7 M	85.3 M	105 M	72.4 M	20.9 M	14 M	3.94 M	5.12 M	3.23 M	5.2 M	9.54 M	8.75 M	17.2 M
Total Shareholders Equity	49.1 M	84.7 M	105 M	72.4 M	20.8 M	14 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet AVITA Medical

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	42.5 M	41 M	41.3 M	39.8 M	1.84 M	1.05 M	1.24 M	306 K	405 K	532 K	726 K	918 K	1.11 M	878 K	878 K	1.24 M	1.78 M	1.92 M	1.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	68.6 M	63.5 M	64 M	61.9 M	17.4 M	16.5 M	14.3 M	13 M	11.7 M	9.95 M	8.68 M	11.4 M	9.68 M	9.85 M	9.85 M	9.71 M	9.93 M	10.1 M	10.1 M	-	-	4.95 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	205 K	-	33 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-348 M	-332 M	-317 M	-298 M	-291 M	-282 M	-272 M	-263 M	-257 M	-252 M	-245 M	-236 M	-227 M	-221 M	-221 M	-211 M	-205 M	-195 M	-195 M	-	-	-153 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	81.1 M	87.8 M	97.4 M	112 M	81 M	86.3 M	92.6 M	98.3 M	99.9 M	103 M	106 M	116 M	121 M	126 M	126 M	69.3 M	75.4 M	82.5 M	82.5 M	-	-	25.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	18.6 M	17.5 M	17 M	22.1 M	50.9 M	37.5 M	28 M	18.2 M	23.8 M	34.9 M	23.7 M	55.5 M	60.7 M	111 M	111 M	59.8 M	65.8 M	73.6 M	73.6 M	87.5 M	15.3 M	20.2 M	-	-	-	11 M	-	-	-	2.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	12.5 M	24.3 M	33.4 M	49.7 M	63.6 M	69.9 M	78.4 M	85.3 M	88.3 M	92.7 M	97.8 M	105 M	111 M	116 M	116 M	59.6 M	65.5 M	72.4 M	72.4 M	-	-	20.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	12.2 M	23.9 M	32.6 M	49.1 M	63 M	68.6 M	77.6 M	84.7 M	88 M	92.6 M	97.8 M	105 M	111 M	116 M	116 M	59.6 M	59.6 M	59.6 M	65.5 M	87.3 M	18 M	20.8 M	-	-	-	14 M	-	-	-	3.93 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency